293 related articles for article (PubMed ID: 2046017)
1. Renal actions of a new adenosine agonist, CGS 21680A selective for the A2 receptor.
Levens N; Beil M; Jarvis M
J Pharmacol Exp Ther; 1991 Jun; 257(3):1005-12. PubMed ID: 2046017
[TBL] [Abstract][Full Text] [Related]
2. Intrarenal actions of the new adenosine agonist CGS 21680A, selective for the A2 receptor.
Levens N; Beil M; Schulz R
J Pharmacol Exp Ther; 1991 Jun; 257(3):1013-9. PubMed ID: 2046018
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular effects of adenosine A2 agonists in the conscious spontaneously hypertensive rat: a comparative study of three structurally distinct ligands.
Webb RL; Barclay BW; Graybill SC
J Pharmacol Exp Ther; 1991 Dec; 259(3):1203-12. PubMed ID: 1684818
[TBL] [Abstract][Full Text] [Related]
4. [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.
Jarvis MF; Schulz R; Hutchison AJ; Do UH; Sills MA; Williams M
J Pharmacol Exp Ther; 1989 Dec; 251(3):888-93. PubMed ID: 2600819
[TBL] [Abstract][Full Text] [Related]
5. Repeated administration of selective adenosine A1 and A2 receptor agonists in the spontaneously hypertensive rat: tolerance develops to A1-mediated hemodynamic effects.
Casati C; Monopoli A; Dionisotti S; Zocchi C; Bonizzoni E; Ongini E
J Pharmacol Exp Ther; 1994 Mar; 268(3):1506-11. PubMed ID: 8138961
[TBL] [Abstract][Full Text] [Related]
6. Effects of adenosine-receptor agonists on renin release in anaesthetized rats.
Protasoni G; Castoldi G; Busca G; Panzacchi G; Genovesi S; Golin R; Stella A
J Hypertens; 1995 Dec; 13(12 Pt 2):1753-7. PubMed ID: 8903646
[TBL] [Abstract][Full Text] [Related]
7. CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity.
Hutchison AJ; Webb RL; Oei HH; Ghai GR; Zimmerman MB; Williams M
J Pharmacol Exp Ther; 1989 Oct; 251(1):47-55. PubMed ID: 2795469
[TBL] [Abstract][Full Text] [Related]
8. Telemetry monitoring of hemodynamic effects induced over time by adenosine agonists in spontaneously hypertensive rats.
Casati C; Monopoli A; Forlani A; Bonizzoni E; Ongini E
J Pharmacol Exp Ther; 1995 Nov; 275(2):914-9. PubMed ID: 7473182
[TBL] [Abstract][Full Text] [Related]
9. Effects of the selective adenosine A2 receptor agonist CGS 21680 on in vitro electrophysiology, cAMP formation and dopamine release in rat hippocampus and striatum.
Lupica CR; Cass WA; Zahniser NR; Dunwiddie TV
J Pharmacol Exp Ther; 1990 Mar; 252(3):1134-41. PubMed ID: 2156991
[TBL] [Abstract][Full Text] [Related]
10. Concentration dependency of the renal vascular and renin secretory responses to adenosine receptor agonists.
Murray RD; Churchill PC
J Pharmacol Exp Ther; 1985 Jan; 232(1):189-93. PubMed ID: 2981315
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes.
Bruns RF; Lu GH; Pugsley TA
Mol Pharmacol; 1986 Apr; 29(4):331-46. PubMed ID: 3010074
[TBL] [Abstract][Full Text] [Related]
12. Relationships among endotoxemia, arterial pressure, and renal function in dogs.
O'Hair DP; Adams MB; Tunberg TC; Osborn JL
Circ Shock; 1989 Mar; 27(3):199-210. PubMed ID: 2650915
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic effects of adenosine agonists in the conscious spontaneously hypertensive rat.
Webb RL; McNeal RB; Barclay BW; Yasay GD
J Pharmacol Exp Ther; 1990 Sep; 254(3):1090-9. PubMed ID: 2203898
[TBL] [Abstract][Full Text] [Related]
14. Role of endothelium-derived relaxing factor in the in vivo renal vascular action of adenosine in dogs.
Okumura M; Miura K; Yamashita Y; Yukimura T; Yamamoto K
J Pharmacol Exp Ther; 1992 Mar; 260(3):1262-7. PubMed ID: 1545391
[TBL] [Abstract][Full Text] [Related]
15. Humoral effects of selective adenosine agonists in spontaneously hypertensive rats.
Sala C; Monopoli A; Alberti C; Casati C; Ongini E; Zanchetti A; Morganti A
J Hypertens; 1996 Jan; 14(1):75-9. PubMed ID: 12013498
[TBL] [Abstract][Full Text] [Related]
16. Characterization of adenosine A2 receptors in bovine retinal membranes.
Blazynski C; McIntosh H
Exp Eye Res; 1993 May; 56(5):585-93. PubMed ID: 8500567
[TBL] [Abstract][Full Text] [Related]
17. Role of central and peripheral adenosine receptors in the cardiovascular responses to intraperitoneal injections of adenosine A1 and A2A subtype receptor agonists.
Schindler CW; Karcz-Kubicha M; Thorndike EB; Müller CE; Tella SR; Ferré S; Goldberg SR
Br J Pharmacol; 2005 Mar; 144(5):642-50. PubMed ID: 15678095
[TBL] [Abstract][Full Text] [Related]
18. Controlled hypotension with adenosine or sodium nitroprusside during cerebral aneurysm surgery: effects on renal hemodynamics, excretory function, and renin release.
Zäll S; Edén E; Winsö I; Volkmann R; Sollevi A; Ricksten SE
Anesth Analg; 1990 Dec; 71(6):631-6. PubMed ID: 2240636
[TBL] [Abstract][Full Text] [Related]
19. Fc gamma receptor-mediated functions in neutrophils are modulated by adenosine receptor occupancy. A1 receptors are stimulatory and A2 receptors are inhibitory.
Salmon JE; Cronstein BN
J Immunol; 1990 Oct; 145(7):2235-40. PubMed ID: 2168919
[TBL] [Abstract][Full Text] [Related]
20. Diuretic and renal protective effects of 8-(noradamantan-3-yl)-1,3-dipropylxanthine (KW-3902), a novel adenosine A1-receptor antagonist, via pertussis toxin insensitive mechanism.
Mizumoto H; Karasawa A; Kubo K
J Pharmacol Exp Ther; 1993 Jul; 266(1):200-6. PubMed ID: 8331558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
